Skip to main content
. 2022 May 27;130(8):515–523. doi: 10.1111/apm.13231

Table 2.

Log10 reductions of Fig. 4

Antibiotic Treatment start (h after inoculation) Log10 reduction compared to
Treatment start Untreated endpoint
Tobramycin 0 −/− 2.6/1.85
3 −/− 0.37/0.36
6 −/− −/−
Ciprofloxacin 0 1.48/1.72 4.8/5
3 2.95/3.29 4.72/5.03
6 0.89/0.48 1.29/0.63
Penicillin 0 1.39 4.71
3 2.17 3.93
6 0.84 1.24
Tobramycin + Ciprofloxacin 0 3.91/3.46 7.23/6.74
3 3.07/3.05 4.83/4.79
6 0.57/0.73 0.97/0.88
Tobramycin + Penicillin 0 2.61 5.94
3 2.63 4.4
6 1.72 2.11
Ciprofloxacin + Penicillin 0 2.14 5.47
3 2.62 4.38
6 2.19 2.59

Note:The means of the values displayed in Fig. 4A and B were calculated. Log10 CFU reductions of the treated samples were set in comparison with colony counts before treatment initiation and to untreated controls at the endpoint. Values seperated by a slash indicate the results for Fig. 4A/B. The “−” indicates no reduction.